Nomura Asset Management’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-25
| Closed | -$1.16K | – | 1631 |
|
|
2023
Q4 | $1.16K | Hold |
25
| – | – | ﹤0.01% | 1532 |
|
|
2023
Q3 | $1.02K | Hold |
25
| – | – | ﹤0.01% | 1544 |
|
|
2023
Q2 | $1.21K | Hold |
25
| – | – | ﹤0.01% | 1551 |
|
|
2023
Q1 | $1.23K | Sell |
25
-12,425
| -100% | -$612K | ﹤0.01% | 1544 |
|
|
2022
Q4 | $630K | Hold |
12,450
| – | – | ﹤0.01% | 848 |
|
|
2022
Q3 | $625K | Buy |
12,450
+12,425
| +49,700% | +$624K | ﹤0.01% | 839 |
|
|
2022
Q2 | $1.65K | Hold |
25
| – | – | ﹤0.01% | 1530 |
|
|
2022
Q1 | $1.5K | Buy |
+25
| New | +$1.5K | ﹤0.01% | 1552 |
|
|
2021
Q4 | – | Sell |
-3,100
| Closed | -$276K | – | 1127 |
|
|
2021
Q3 | $276K | Hold |
3,100
| – | – | ﹤0.01% | 904 |
|
|
2021
Q2 | $309K | Hold |
3,100
| – | – | ﹤0.01% | 936 |
|
|
2021
Q1 | $279K | Buy |
+3,100
| New | +$279K | ﹤0.01% | 923 |
|